GH Research to present GH001 depression trial data at ECNP 2026 meeting

Bitget2026/10/09 11:02

GH Research plc set three posters for ECNP 2026 featuring data from its GH001-TRD-201 and GH001-BD-202 depression trials. Results have not yet been presented; disclosures are scheduled for Poster Session 2 on Oct. 11, 2026, in Munich. Planned presentations focus on clinical findings from studies in treatment-resistant depression and bipolar depression, without reporting outcomes in the announcement. An ECNP industry satellite symposium on rapid-acting antidepressants is scheduled for Oct. 10, 2026. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GH Research plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-039191), on October 09, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Dow Jones Top Energy Headlines at 12 AM ET: Oil Futures Slide As Market Holds Out Hopes for Middle East Diplomacy | Energy ...

Dow Jones•2026/11/09 05:00

United States Dollar Index remains subdued as lower oil prices ease inflation pressure

FXStreet•2026/11/09 04:54

Citi is bullish on the Indian stock market, expecting the Nifty Index to rise to 28,000 points by the end of 2027.

路透社•2026/11/09 04:06

Silver Price Forecast: XAG/USD rises to near $53.00 as lower oil eases inflation pressure

FXStreet•2026/11/09 03:39